378 related articles for article (PubMed ID: 16763590)
1. Insights into US public biotech sector using patenting trends.
Aggarwal S; Gupta V; Bagchi-Sen S
Nat Biotechnol; 2006 Jun; 24(6):643-51. PubMed ID: 16763590
[TBL] [Abstract][Full Text] [Related]
2. Biotech patenting matures.
Lawrence S
Nat Biotechnol; 2004 Oct; 22(10):1202. PubMed ID: 15470446
[No Abstract] [Full Text] [Related]
3. Biotech patenting slows in 2004.
Lawrence S
Nat Biotechnol; 2005 Oct; 23(10):1198. PubMed ID: 16211048
[No Abstract] [Full Text] [Related]
4. Public biotechnology 2005--the numbers.
Lähteenmäki R; Lawrence S
Nat Biotechnol; 2006 Jun; 24(6):625-34. PubMed ID: 16763588
[TBL] [Abstract][Full Text] [Related]
5. Public biotech 2006 - the numbers.
Lähteenmäki R; Lawrence S
Nat Biotechnol; 2007 Jul; 25(7):729-37. PubMed ID: 17621294
[No Abstract] [Full Text] [Related]
6. Biotech patents still strong.
Lawrence S
Nat Biotechnol; 2007 Dec; 25(12):1341. PubMed ID: 18066014
[No Abstract] [Full Text] [Related]
7. Patent holdings of US biotherapeutic companies in major markets.
Sebastian TE; Yerram CB; Saberwal G
Drug Discov Today; 2009 May; 14(9-10):442-5. PubMed ID: 19429502
[TBL] [Abstract][Full Text] [Related]
8. The public-private structure of intellectual property ownership in agricultural biotechnology.
Graff GD; Cullen SE; Bradford KJ; Zilberman D; Bennett AB
Nat Biotechnol; 2003 Sep; 21(9):989-95. PubMed ID: 12949559
[No Abstract] [Full Text] [Related]
9. Public biotech 2010--the numbers.
Huggett B; Hodgson J; Lähteenmäki R
Nat Biotechnol; 2011 Jul; 29(7):585-91. PubMed ID: 21747381
[No Abstract] [Full Text] [Related]
10. The rise and fall of innovation in biofuels.
Albers SC; Berklund AM; Graff GD
Nat Biotechnol; 2016 Aug; 34(8):814-21. PubMed ID: 27504772
[No Abstract] [Full Text] [Related]
11. Public markets show signs of life.
Mitchell P
Nat Biotechnol; 2003 Aug; 21(8):833-4. PubMed ID: 12894181
[No Abstract] [Full Text] [Related]
12. State of biotech sector--2005.
Lawrence S
Nat Biotechnol; 2006 Jun; 24(6):603. PubMed ID: 16763577
[No Abstract] [Full Text] [Related]
13. Private biotech 2004--the numbers.
Hodgson J
Nat Biotechnol; 2006 Jun; 24(6):635-41. PubMed ID: 16763589
[TBL] [Abstract][Full Text] [Related]
14. Public biotech 2009-the numbers.
Huggett B; Hodgson J; Lähteenmäki R
Nat Biotechnol; 2010 Aug; 28(8):793-9. PubMed ID: 20697401
[No Abstract] [Full Text] [Related]
15. Patent drop reveals pressures on industry.
Lawrence S
Nat Biotechnol; 2004 Aug; 22(8):930-1. PubMed ID: 15286630
[No Abstract] [Full Text] [Related]
16. The responsibilities of growing up.
Nat Biotechnol; 2006 Mar; 24(3):225. PubMed ID: 16525362
[No Abstract] [Full Text] [Related]
17. Korean biotechs seize opportunity to list on public markets.
Louët S
Nat Biotechnol; 2005 Oct; 23(10):1189-90. PubMed ID: 16211042
[No Abstract] [Full Text] [Related]
18. Biotech patenting upturn.
Lawrence S
Nat Biotechnol; 2006 Oct; 24(10):1190. PubMed ID: 17033646
[No Abstract] [Full Text] [Related]
19. Enthusiasm cools in Q2.
Lawrence S
Nat Biotechnol; 2005 Aug; 23(8):914. PubMed ID: 16082352
[No Abstract] [Full Text] [Related]
20. We speak for small biotech.
Sherwin SA
Nat Biotechnol; 2008 Jan; 26(1):27. PubMed ID: 18183009
[No Abstract] [Full Text] [Related]
[Next] [New Search]